Literature DB >> 9846580

Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever.

V Vidal1, I G Scragg, S J Cutler, K A Rockett, D Fekade, D A Warrell, D J Wright, D Kwiatkowski.   

Abstract

Massive release of tumor necrosis factor is responsible for the potentially fatal larisch-Herxheimer reaction that follows antibiotic treatment of relapsing fever due to Borrelia recurrentis. We have undertaken the quantitative purification of the components of B. recurrentis that stimulate human monocytes to produce tumor necrosis factor. We show that the predominant factor inducing tumor necrosis factor is a variable lipoprotein homologous to the variable major protein of B. hermsii. We found antibodies to different forms of variable major protein in two patients with louse-borne relapsing fever. The three purified variable major proteins studied here differ in their ability to induce tumor necrosis factor production, which may partly explain the variable clinical severity of borrelial infection. These results may be of considerable relevance for the pathogenesis of Lyme disease and other forms of human borreliosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846580     DOI: 10.1038/4007

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  25 in total

1.  Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae.

Authors:  Harald Gelderblom; Jens Schmidt; Diana Londoño; Yunhong Bai; Jacqueline Quandt; Ron Hornung; Adriana Marques; Roland Martin; Diego Cadavid
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Release of Toll-like receptor-2-activating bacterial lipoproteins in Shigella flexneri culture supernatants.

Authors:  A O Aliprantis; D S Weiss; J D Radolf; A Zychlinsky
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis.

Authors:  Zhi-Yong Peng; Hong-Zhi Wang; Nattachai Srisawat; Xiaoyan Wen; Thomas Rimmelé; Jeffery Bishop; Kai Singbartl; Raghavan Murugan; John A Kellum
Journal:  Crit Care Med       Date:  2012-02       Impact factor: 7.598

5.  Dual role of MyD88 in rapid clearance of relapsing fever Borrelia spp.

Authors:  Devin D Bolz; Rhianna S Sundsbak; Ying Ma; Shizuo Akira; John H Weis; Tom G Schwan; Janis J Weis
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

6.  Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice.

Authors:  A Nordstrand; A Shamaei-Tousi; A Ny; S Bergström
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Induction of interleukin-8 in T84 cells by Vibrio cholerae.

Authors:  Xin Zhou; Da Q Gao; Jane Michalski; Jorge A Benitez; James B Kaper
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 8.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

9.  Real-time monitoring of disease progression in rhesus macaques infected with Borrelia turicatae by tick bite.

Authors:  Job E Lopez; Heather Vinet-Oliphant; Hannah K Wilder; Christopher P Brooks; Britton J Grasperge; Timothy W Morgan; Kerstan J Stuckey; Monica E Embers
Journal:  J Infect Dis       Date:  2014-05-30       Impact factor: 5.226

10.  A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice.

Authors:  Christer Larsson; Jenny Lundqvist; Nico van Rooijen; Sven Bergström
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.